TokenPost·

Omeros Forecasts $5 Million to $6 Million in Q4 Discontinued-Operations Income

Your call?

YARTEMLEA gross revenue rose 29.6% sequentially in Q3. Medicare’s revised outpatient payment rate for 340B-acquired drugs, including YARTEMLEA, takes effect Jan. 1, 2027.

Share

More news